Charles River Laboratories International, Inc. (CRL) vs Medpace Holdings, Inc. (MEDP)
- Charles River Laboratories International, Inc. CRL 299.77 −2.11%
- Medpace Holdings, Inc. MEDP 618.47 −1.61%
Charles River Laboratories International, Inc. and Medpace Holdings, Inc. are both Diagnostics & Research companies. Medpace Holdings, Inc. is the larger, with a market value of $17.6B against $14.6B — 1.2× the size. Charles River Laboratories International, Inc. has negative trailing earnings, so its P/E is not meaningful; Medpace Holdings, Inc. trades at 35.6×. Medpace Holdings, Inc. grew revenue faster over the last twelve months: 24.7% against −0.74%. Medpace Holdings, Inc. has the higher net margin (17.7% vs −5.96%) and the lower return on invested capital (0.00% vs 1.07%). Across the 21 metrics below, Medpace Holdings, Inc. leads on 16 and Charles River Laboratories International, Inc. on 5.
Valuation
Profitability
| Metric | CRL | MEDP | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 32.67% | 72.35% | 50.89% |
| Operating margin | 2.25% | 20.97% | (8.57%) |
| Net margin | (5.96%) | 17.67% | (6.37%) |
| Free cash flow margin | 9.27% | 25.40% | 0.00% |
| Return on equity | (7.69%) | 162.15% | (2.92%) |
| Return on assets | (3.16%) | 27.09% | (6.71%) |
| Return on invested capital | 1.07% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack